Jeryl L Hilleman - Net Worth and Insider Trading

Jeryl L Hilleman Net Worth

The estimated net worth of Jeryl L Hilleman is at least $1 Million dollars as of 2024-09-20. Jeryl L Hilleman is the CFO of Intersect ENT Inc and owns about 31,884 shares of Intersect ENT Inc (XENT) stock worth over $900,404. Jeryl L Hilleman is the Director of SI-BONE Inc and owns about 15,349 shares of SI-BONE Inc (SIBN) stock worth over $241,747. Jeryl L Hilleman is also the Director of NovoCure Ltd and owns about 2,537 shares of NovoCure Ltd (NVCR) stock worth over $44,220. Besides these, Jeryl L Hilleman also holds Minerva Neurosciences Inc (NERV) , Amyris Inc (AMRSQ) . Details can be seen in Jeryl L Hilleman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeryl L Hilleman has not made any transactions after 2023-06-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Jeryl L Hilleman

Jeryl L Hilleman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jeryl L Hilleman owns 9 companies in total, including SI-BONE Inc (SIBN) , Minerva Neurosciences Inc (NERV) , and NovoCure Ltd (NVCR) among others .

Click here to see the complete history of Jeryl L Hilleman’s form 4 insider trades.

Insider Ownership Summary of Jeryl L Hilleman

Ticker	Comapny	Transaction Date	Type of Owner
SIBN	SI-BONE Inc	2023-06-20	director
NERV	Minerva Neurosciences Inc	2019-06-26	director
NVCR	NovoCure Ltd	2022-06-10	director
		2019-04-02	Chief Financial Officer
		2016-07-05	director
		2013-12-19	CFO and Secretary
		2011-05-20	Chief Financial Officer
		2021-03-16	director
		2022-04-28	director

Jeryl L Hilleman Latest Holdings Summary

Jeryl L Hilleman currently owns a total of 5 stocks. Among these stocks, Jeryl L Hilleman owns 31,884 shares of Intersect ENT Inc (XENT) as of April 2, 2019, with a value of $900,404 and a weighting of 75.87%. Jeryl L Hilleman owns 15,349 shares of SI-BONE Inc (SIBN) as of June 20, 2023, with a value of $241,747 and a weighting of 20.37%. Jeryl L Hilleman also owns 2,537 shares of NovoCure Ltd (NVCR) as of June 10, 2022, with a value of $44,220 and a weighting of 3.73%. The other 2 stocks Minerva Neurosciences Inc (NERV) , Amyris Inc (AMRSQ) have a combined weighting of 0.03% among all his current holdings.

Latest Holdings of Jeryl L Hilleman

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
XENT	Intersect ENT Inc	2019-04-02	31,884	28.24	900,404
SIBN	SI-BONE Inc	2023-06-20	15,349	15.75	241,747
NVCR	NovoCure Ltd	2022-06-10	2,537	17.43	44,220
NERV	Minerva Neurosciences Inc	2019-06-26	125	2.83	353
AMRSQ	Amyris Inc	2011-05-20	594	0.00	1

Holding Weightings of Jeryl L Hilleman

Jeryl L Hilleman Form 4 Trading Tracker

According to the SEC Form 4 filings, Jeryl L Hilleman has made a total of 0 transactions in Intersect ENT Inc (XENT) over the past 5 years. The most-recent trade in Intersect ENT Inc is the sale of 51,200 shares on April 2, 2019, which brought Jeryl L Hilleman around $2 Million.

According to the SEC Form 4 filings, Jeryl L Hilleman has made a total of 3 transactions in SI-BONE Inc (SIBN) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in SI-BONE Inc is the sale of 4,162 shares on June 20, 2023, which brought Jeryl L Hilleman around $118,076.

According to the SEC Form 4 filings, Jeryl L Hilleman has made a total of 2 transactions in NovoCure Ltd (NVCR) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in NovoCure Ltd is the sale of 407 shares on June 10, 2022, which brought Jeryl L Hilleman around $28,331.

More details on Jeryl L Hilleman's insider transactions can be found in the Insider Trading History of Jeryl L Hilleman table.

Insider Trading History of Jeryl L Hilleman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jeryl L Hilleman Trading Performance

GuruFocus tracks the stock performance after each of Jeryl L Hilleman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeryl L Hilleman is 52.6%. GuruFocus also compares Jeryl L Hilleman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeryl L Hilleman within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jeryl L Hilleman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jeryl L Hilleman

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	20.22
Relative Return to S&P 500(%)	16.37

Jeryl L Hilleman Ownership Network

Ownership Network List of Jeryl L Hilleman

No Data

Ownership Network Relation of Jeryl L Hilleman

Jeryl L Hilleman Owned Company Details

What does SI-BONE Inc do?

Who are the key executives at SI-BONE Inc?

Jeryl L Hilleman is the director of SI-BONE Inc. Other key executives at SI-BONE Inc include Chief Financial Officer Anshul Maheshwari , Chief Commercial Officer Anthony J Recupero , and Chief Financial Officer Laura Francis .

SI-BONE Inc (SIBN) Insider Trades Summary

Over the past 18 months, Jeryl L Hilleman made 1 insider transaction in SI-BONE Inc (SIBN) with a net sale of 4,162. Other recent insider transactions involving SI-BONE Inc (SIBN) include a net sale of 361,979 shares made by Jeffrey W Dunn , a net sale of 56,302 shares made by Anthony J Recupero , and a net sale of 27,556 shares made by Anshul Maheshwari .

In summary, during the past 3 months, insiders sold 29,252 shares of SI-BONE Inc (SIBN) in total and bought 0 shares, with a net sale of 29,252 shares. During the past 18 months, 520,387 shares of SI-BONE Inc (SIBN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 520,387 shares.

SI-BONE Inc (SIBN)'s detailed insider trading history can be found in Insider Trading Tracker table.

SI-BONE Inc Insider Transactions

No Available Data

What does Minerva Neurosciences Inc do?

Who are the key executives at Minerva Neurosciences Inc?

Jeryl L Hilleman is the director of Minerva Neurosciences Inc. Other key executives at Minerva Neurosciences Inc include 10 percent owner Ag Boehringer , 10 percent owner Boehringer Ingelheim International Gmbh , and EVP and Head of R&D Remy Luthringer .

Minerva Neurosciences Inc (NERV) Insider Trades Summary

Over the past 18 months, Jeryl L Hilleman made no insider transaction in Minerva Neurosciences Inc (NERV). Other recent insider transactions involving Minerva Neurosciences Inc (NERV) include a net sale of 27,394 shares made by Remy Luthringer , a net sale of 22,082 shares made by Geoff Race , and a net sale of 3,580 shares made by Frederick W Ahlholm .

In summary, during the past 3 months, insiders sold 0 shares of Minerva Neurosciences Inc (NERV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 53,056 shares of Minerva Neurosciences Inc (NERV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 53,056 shares.

Minerva Neurosciences Inc (NERV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Minerva Neurosciences Inc Insider Transactions

No Available Data

What does NovoCure Ltd do?

Who are the key executives at NovoCure Ltd?

Jeryl L Hilleman is the director of NovoCure Ltd. Other key executives at NovoCure Ltd include Chief Financial Officer Ashley Cordova , Chief Financial Officer Wilhelmus Cm Groenhuysen , and President & CNS Cancers US Frank X Leonard .

NovoCure Ltd (NVCR) Insider Trades Summary

Over the past 18 months, Jeryl L Hilleman made no insider transaction in NovoCure Ltd (NVCR). Other recent insider transactions involving NovoCure Ltd (NVCR) include a net sale of 5,921 shares made by Wilhelmus Cm Groenhuysen , a net sale of 2,715 shares made by Ashley Cordova , and a net sale of 4,597 shares made by Frank X Leonard .

In summary, during the past 3 months, insiders sold 688 shares of NovoCure Ltd (NVCR) in total and bought 0 shares, with a net sale of 688 shares. During the past 18 months, 16,780 shares of NovoCure Ltd (NVCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 16,780 shares.

NovoCure Ltd (NVCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

NovoCure Ltd Insider Transactions

No Available Data

What does Intersect ENT Inc do?

Who are the key executives at Intersect ENT Inc?

Jeryl L Hilleman is the Chief Financial Officer of Intersect ENT Inc. Other key executives at Intersect ENT Inc include EVP & GC & Corporate Secretary Patrick A Broderick , Chief Human Resource Officer Reyna M Fernandez , and director & President and CEO Thomas A. West .

Intersect ENT Inc (XENT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Intersect ENT Inc (XENT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Intersect ENT Inc (XENT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Intersect ENT Inc (XENT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Intersect ENT Inc Insider Transactions

No Available Data

What does XenoPort Inc do?

Who are the key executives at XenoPort Inc?

Jeryl L Hilleman is the director of XenoPort Inc. Other key executives at XenoPort Inc include See Remarks William G Harris , 10 percent owner & other: Possible Member of 10% Group Deerfield Management Company, L.p. (series C) , and 10 percent owner & other: Possible Member of 10% Group Deerfield Mgmt L.p. .

XenoPort Inc (XNPT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of XenoPort Inc (XNPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of XenoPort Inc (XNPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

XenoPort Inc (XNPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

XenoPort Inc Insider Transactions

No Available Data

What does Ocera Therapeutics Inc do?

Who are the key executives at Ocera Therapeutics Inc?

Jeryl L Hilleman is the CFO and Secretary of Ocera Therapeutics Inc. Other key executives at Ocera Therapeutics Inc include 10 percent owner Brian H Dovey , 10 percent owner Domain Partners Viii, L.p. , and 10 percent owner Dp Viii Associates, L.p. .

Ocera Therapeutics Inc (OCRX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ocera Therapeutics Inc (OCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ocera Therapeutics Inc (OCRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ocera Therapeutics Inc (OCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ocera Therapeutics Inc Insider Transactions

No Available Data

What does Amyris Inc do?

Who are the key executives at Amyris Inc?

Jeryl L Hilleman is the Chief Financial Officer of Amyris Inc. Other key executives at Amyris Inc include Chief Restructuring Officer Philip J. Gund , Chief Financial Officer Hermanus Kieftenbeld , and Chief Operating Officer Eduardo Alvarez .

Amyris Inc (AMRSQ) Insider Trades Summary

Over the past 18 months, Jeryl L Hilleman made no insider transaction in Amyris Inc (AMRSQ). Other recent insider transactions involving Amyris Inc (AMRSQ) include a net sale of 231,368 shares made by Eduardo Alvarez , and a net sale of 20,999 shares made by Hermanus Kieftenbeld .

In summary, during the past 3 months, insiders sold 0 shares of Amyris Inc (AMRSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 252,367 shares of Amyris Inc (AMRSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 252,367 shares.

Amyris Inc (AMRSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Amyris Inc Insider Transactions

No Available Data

What does Talis Biomedical Corp do?

Who are the key executives at Talis Biomedical Corp?

Jeryl L Hilleman is the director of Talis Biomedical Corp. Other key executives at Talis Biomedical Corp include President & other: Chief Scientific Officer Andrew A Lukowiak , Interim CFO Rebecca Markovich , and director & 10 percent owner Julian Baker .

Talis Biomedical Corp (TLIS) Insider Trades Summary

Over the past 18 months, Jeryl L Hilleman made no insider transaction in Talis Biomedical Corp (TLIS). Other recent insider transactions involving Talis Biomedical Corp (TLIS) include a net purchase of 45,133 shares made by Braden Michael Leonard ,

In summary, during the past 3 months, insiders sold 0 shares of Talis Biomedical Corp (TLIS) in total and bought 45,133 shares, with a net purchase of 45,133 shares. During the past 18 months, 0 shares of Talis Biomedical Corp (TLIS) were sold and 45,133 shares were bought by its insiders, resulting in a net purchase of 45,133 shares.

Talis Biomedical Corp (TLIS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Talis Biomedical Corp Insider Transactions

No Available Data

What does HilleVax Inc do?

Who are the key executives at HilleVax Inc?

Jeryl L Hilleman is the director of HilleVax Inc. Other key executives at HilleVax Inc include director & Chief Operating Officer Aditya Kohli , 10 percent owner Frazier Life Sciences X, L.p. , and director & President and CEO Robert Hershberg .

HilleVax Inc (HLVX) Insider Trades Summary

Over the past 18 months, Jeryl L Hilleman made no insider transaction in HilleVax Inc (HLVX). Other recent insider transactions involving HilleVax Inc (HLVX) include a net sale of 111,764 shares made by Aditya Kohli , a net sale of 48,933 shares made by Astrid Borkowski , and a net sale of 11,597 shares made by Robert Hershberg .

In summary, during the past 3 months, insiders sold 0 shares of HilleVax Inc (HLVX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 175,870 shares of HilleVax Inc (HLVX) were sold and 10,100 shares were bought by its insiders, resulting in a net sale of 165,770 shares.

HilleVax Inc (HLVX)'s detailed insider trading history can be found in Insider Trading Tracker table.

HilleVax Inc Insider Transactions

No Available Data

Jeryl L Hilleman Mailing Address

Above is the net worth, insider trading, and ownership report for Jeryl L Hilleman. You might contact Jeryl L Hilleman via mailing address: C/o Intersect Ent, Inc., 1555 Adams Drive, Menlo Park Ca 94025.

Discussions on Jeryl L Hilleman

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.